Cited by 2,803Cancer-related Molecular PathwaysDNA Repair MechanismsMicrotubule and mitosis dynamics

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., Vogelstein, B.·1998·Science

DOI 10.1126/science.282.5393.1497

Open this paper in CoChat — free account

Abstract

After DNA damage, many cells appear to enter a sustained arrest in the G 2 phase of the cell cycle. It is shown here that this arrest could be sustained only when p53 was present in the cell and capable of transcriptionally activating the cyclin-dependent kinase inhibitor p21. After disruption of either the p53 or the p21 gene, γ radiated cells progressed into mitosis and exhibited a G 2 DNA content only because of a failure of cytokinesis. Thus, p53 and p21 appear to be essential for maintaining the G 2 checkpoint in human cells.

Integrity signals

Registry

Crossref · 10.1126/science.282.5393.1497

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citation
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798
Cell Cycle Control and Cancer
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,490
Self-citation
Mitotic and G 2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citation

Show all 50 references

Research works printed but not linked: 13

Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W., Cancer Res. 51, 6304 (1991);
Waldman T., Kinzler K. W., Vogelstein B., Cancer Res. 55, 5187 (1995).
Powell S. N., et al., Cancer Res. 55, 1643 (1995);
Fan S., et al., Cancer Res. 55, 1649 (1995);
Russell K. J., et al., ibid. 55, 1639 (1995).
Khan S. H., Wahl G. M., Cancer Res. 58, 396 (1998);
Michieli P., et al., Cancer Res. 54, 3391 (1994);
Paules R. S., et al., Cancer Res 55, 1763 (1995);
Stewart N., Hicks G. G., Paraskeva F., Mowat M., Oncogene 10, 109 (1995).
Li Y., Jenkins C. W., Nichols M. A., Xiong Y., Oncogene 9, 2261 (1994).
Niculescu A. B., et al., Mol. Cell. Biol. 18, 629 (1998). · DOI
El-Deiry W. S., et al., Cancer Res. 55, 2910 (1995);
Kaufmann K., et al., Cell Growth. Diff. 8, 1105 (1997);

Sorted by citations

Items 901–1,000 of 1,018

Inhibition of Cell Division by the Human Cytomegalovirus IE86 Protein: Role of the p53 Pathway or Cyclin-Dependent Kinase 1/Cyclin B1
Song, Y., & Stinski, M. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2597-2603.2005 · Cited by 63
The effect of sulforaphane on the cell cycle, apoptosis and expression of cyclin D1 and p21 in the A549 non-small cell lung cancer cell line
Żuryń, A., Litwiniec, A., Safiejko‐Mroczka, B., Klimaszewska‐Wiśniewska, A., Gagat, M., Krajewski, A., Gackowska, L., & Grzanka, D. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3444 · Cited by 63
Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality
Szmyd, R., Niska-Blakie, J., Diril, M. K., Nunes, P. R., Tzelepis, K., Lacroix, A., Hul, N. V., Deng, L., Matos, J., Dreesen, O., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0464-0 · Cited by 63
Targeting cellular metabolism to reduce head and neck cancer growth
Yang, J., Guo, Y., Seo, W., Zhang, R., Lu, C., Wang, Y. E., Luo, L., Paul, B., Yan, W., Saxena, D. B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41523-4 · Cited by 64
p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A
Rother, K., Kirschner, R., Sänger, K., Böhlig, L., Mössner, J., & Engeland, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209989 · Cited by 63
Invited Review: Effect of oxygen deprivation on cell cycle activity: a profile of delay and arrest
Douglas, R. M., & Haddad, G. G. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01029.2002 · Cited by 65
A Functional Role for p38 MAPK in Modulating Mitotic Transit in the Absence of Stress
Cha, H., Wang, X., Li, H., & Fornace, A. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700735200 · Cited by 63
Molecular Mechanisms of Cell Cycle Block by Methionine Restriction in Human Prostate Cancer Cells
Lu, S., & Epner, D. E. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc381_17 · Cited by 63
Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival
Meng, L., Lin, T., & Tsai, R. Y. L. (2008) · Journal of Cell Science · doi:10.1242/jcs.037952 · Cited by 63
CD30-mediated cell cycle arrest associated with induced expression of p21CIP1/WAF1 in the anaplastic large cell lymphoma cell line Karpas 299
Hübinger, G., Müller, E., Scheffrahn, I., Schneider, C., Hildt, E., Singer, B. B., Sigg, I., Graf, J., & Bergmann, L. (2001) · Oncogene · doi:10.1038/sj.onc.1204128 · Cited by 63
Growth Hormone Exerts Antiapoptotic and Proliferative Effects through Two Different Pathways Involving Nuclear Factor- B and Phosphatidylinositol 3-Kinase
Jeay, S., Sonenshein, G. E., Kelly, P. A., Postel-Vinay, M. C., & Baixerás, E. (2001) · Endocrinology · doi:10.1210/endo.142.1.7892 · Cited by 63
A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance
Yu, J., Kerbel, R. S., & Coomber, B. L. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700913.x · Cited by 65
Targeting Cancer Cells via the Reactive Oxygen Species-Mediated Unfolded Protein Response with a Novel Synthetic Polyphenol Conjugate
Shin, S. Y., Lee, J. M., Lee, M. S., Koh, D., Jung, H., Lim, Y., & Lee, Y. H. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0424 · Cited by 62
Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein
Fischer, M., Quaas, M., Wintsche, A., Müller, G. A., & Engeland, K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt849 · Cited by 66
Protein kinase CK2 is involved in G2 arrest and apoptosis following spindle damage in epithelial cells
Sayed, M., Pelech, S., Wong, C., Marotta, A., & Salh, B. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204894 · Cited by 62
Dnmt1 is essential to maintain progenitors in the perinatal intestinal epithelium
Elliott, E. N., Sheaffer, K. L., Schug, J., Stappenbeck, T. S., & Kaestner, K. H. (2015) · Development · doi:10.1242/dev.117341 · Cited by 63
T-Type Ca2+ Channel Inhibition Induces p53-Dependent Cell Growth Arrest and Apoptosis through Activation of p38-MAPK in Colon Cancer Cells
Dziegielewska, B., Brautigan, D. L., Larner, J. M., & Dziegielewski, J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0485 · Cited by 64
Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner
Aoki, S., Kong, D., Suna, H., Sowa, Y., Sakai, T., Setiawan, A., & Kobayashi, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.119 · Cited by 62
Caffeine induces G2/M arrest and apoptosis via a novel p53‐dependent pathway in NB4 promyelocytic leukemia cells
Ito, K., Nakazato, T., Miyakawa, Y., Yamato, K., Ikeda, Y., & Kizaki, M. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10289 · Cited by 62
APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy
Bucur, O. (2006) · Frontiers in bioscience · doi:10.2741/1903 · Cited by 62
Protein kinases controlling the onset of mitosis
Ferrari, S. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5515-3 · Cited by 65
Mdm2 Is Required for Inhibition of Cdk2 Activity by p21, Thereby Contributing to p53-Dependent Cell Cycle Arrest
Giono, L. E., & Manfredi, J. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01967-06 · Cited by 62
Role for p53 in Gene Induction by Double-Stranded RNA
Hummer, B. T., Li, X.-L., & Hassel, B. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7774-7777.2001 · Cited by 62
Proteasome Inhibitors Induce p53-Independent Apoptosis in Human Cancer Cells
Pandit, B., & Gartel, A. L. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.010 · Cited by 62
Trifluridine Induces p53-Dependent Sustained G2 Phase Arrest with Its Massive Misincorporation into DNA and Few DNA Strand Breaks
Matsuoka, K., Iimori, M., Niimi, S., Tsukihara, H., Watanabe, S., Kiyonari, S., Kiniwa, M., Ando, K., Tokunaga, E., Saeki, H., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0236 · Cited by 61
Cancer cells that survive checkpoint adaptation contain micronuclei that harbor damaged DNA
Lewis, C. W., & Golsteyn, R. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1231287 · Cited by 62
p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin expression.
Mueller, S., Cadenas, E., & Schönthal, A. H. (2000) · PubMed · Cited by 61
Promoter-specific p53-dependent histone acetylation following DNA damage
Kaeser, M. D., & Iggo, R. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207536 · Cited by 62
Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2
Zhao, L., Liu, J., Sidhu, G. S., Niu, Y., Liu, Y., Wang, R., & Liao, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406743200 · Cited by 61
p53 promotes selection for Fas-mediated apoptotic resistance.
Maecker, H. L., Koumenis, C., & Giaccia, A. J. (2000) · PubMed · Cited by 61
P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
Fernández‐Aroca, D. M., Roche, O., Sabater, S., Pascual‐Serra, R., Ortega‐Muelas, M., Sánchez‐Pérez, I., Belandia, B., Ruiz‐Hidalgo, M. J., & Sánchez‐Prieto, R. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.049 · Cited by 60
Citrus limon L.-Derived Nanovesicles Show an Inhibitory Effect on Cell Growth in p53-Inactivated Colorectal Cancer Cells via the Macropinocytosis Pathway
Takakura, H., Nakao, T., Narita, T., Horinaka, M., Ise‐Nakao, Y., Yamamoto, T., Iizumi, Y., Watanabe, M., Sowa, Y., Oda, K., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10061352 · Cited by 60
High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis
Robert, V., Michel, P., Flaman, J., Chiron, A., Martin, C., Charbonnier, F., Paillot, B., & Frébourg, T. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.563 · Cited by 60
Rb2/p130 is the dominating pocket protein in the p53–p21 DNA damage response pathway leading to senescence
Helmbold, H., Komm, N., Deppert, W., & Bohn, W. (2009) · Oncogene · doi:10.1038/onc.2009.222 · Cited by 63
The Hepatitis B Virus X Protein Sensitizes HepG2 Cells to UV Light-induced DNA Damage
Lee, A. T. C., Ren, J., Wong, E.-T., Ban, K. H.-K., Lee, L. A., & Lee, C. G. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506628200 · Cited by 60
Inhibition of DNA-Dependent Protein Kinase Induces Accelerated Senescence in Irradiated Human Cancer Cells
Azad, A., Jackson, S., Cullinane, C. M., Natoli, A. L., Neilsen, P. M., Callen, D. F., Maira, S.-M., Hackl, W., McArthur, G. A., & Solomon, B. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0312 · Cited by 60
CtBP2 Promotes Human Cancer Cell Migration by Transcriptional Activation of Tiam1
Paliwal, S., Ho, N., Parker, D., & Grossman, S. R. (2012) · Genes & Cancer · doi:10.1177/1947601912463695 · Cited by 60
Identification of Preferred Chemotherapeutics for Combining with a CHK1 Inhibitor
Xiao, Y., Ramiscal, J. A. B., Kowanetz, K., Nagro, C. J. D., Malek, S., Evangelista, M., Blackwood, E. R., Jackson, P. K., & O’Brien, T. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0404 · Cited by 60
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
Wirth, M., Stojanovic, N., Christian, J. G., Paul, M. C., Stauber, R. H., Schmid, R. M., Häcker, G. A., Krämer, O. H., Saur, D., & Schneider, G. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku763 · Cited by 62
Comparative Phosphoproteomic Analysis of Checkpoint Recovery Identifies New Regulators of the DNA Damage Response
Halim, V. A., Álvarez‐Fernández, M., Xu, Y. J., Aprelia, M., van den Toorn, H., Heck, A. J. R., Mohammed, S., & Medema, R. H. (2013) · Science Signaling · doi:10.1126/scisignal.2003664 · Cited by 60
Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties
Shchekotikhin, A. E., Dezhenkova, L. G., Цветков, В. Б., Luzikov, Y. N., Volodina, Y. L., Tatarskiy, V. V., Kalinina, A. A., Treschalin, M. I., Treshalina, H. M., Романенко, В. И., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.050 · Cited by 60
Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest
Rai, P., He, F., Kwang, J., Engelward, B. P., & Chow, V. T. K. (2016) · Scientific Reports · doi:10.1038/srep22972 · Cited by 65
Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway
Zeriouh, W., Nani, A., Belarbi, M., Dumont, A., de Rosny, C., Aboura, I., Ghanemi, F. Z., Murtaza, B., Patoli, D., Thomas, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170823 · Cited by 60
Mitochondrial inner membrane protein (mitofilin) knockdown induces cell death by apoptosis via an AIF-PARP-dependent mechanism and cell cycle arrest
Madungwe, N. B., Feng, Y., Lie, M. L., Tombo, N., Liu, L., Kaya, F., & Bopassa, J. C. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2017 · Cited by 60
Revisiting Cationic Phosphorus Dendrimers as a Nonviral Vector for Optimized Gene Delivery Toward Cancer Therapy Applications
Chen, L., Li, J., Fan, Y., Qiu, J., Cao, L., Laurent, R., Mignani, S. M., Caminade, A., Majoral, J., & Shi, X. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00458 · Cited by 61
DNMT1 knockout delivers a strong blow to genome stability and cell viability
Brown, K. D., & Robertson, K. D. (2007) · Nature Genetics · doi:10.1038/ng0307-289 · Cited by 60
Extracellular zinc stimulates ERK‐dependent activation of p21Cip/WAF1 and inhibits proliferation of colorectal cancer cells
Park, K., Ahn, Y., Kim, J., Yun, M.-S., Seong, B. L., & Choi, K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704909 · Cited by 60
HIV-1 Vpr Activates Cell Cycle Inhibitor p21/Waf1/Cip1: A Potential Mechanism of G2/M Cell Cycle Arrest
Chowdhury, I. H., Wang, X., Landau, N. R., Robb, M. L., Polonis, V. R., Birx, D. L., & Kim, J. H. (2003) · Virology · doi:10.1006/viro.2002.1777 · Cited by 60
E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma
Crosby, M. E., Jacobberger, J. W., Gupta, D., Macklis, R. M., & Almasan, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209998 · Cited by 60
Induction of endoplasmic reticulum stress by ellipticine plant alkaloids
Hägg, M., Berndtsson, M., Mandic, A., Zhou, R., Shoshan, M. C., & Linder, S. T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.489.3.4 · Cited by 60
Identification of a Bis-guanylhydrazone [4,4′-Diacetyldiphenylurea-bis(guanylhydrazone); NSC 109555] as a Novel Chemotype for Inhibition of Chk2 Kinase
Jobson, A. G., Cardellina, J. H., Scudiero, D. A., Kondapaka, S. B., Zhang, H., Kim, H., Shoemaker, R. H., & Pommier, Y. G. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035832 · Cited by 62
Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells
Palrasu, M., Zaika, E. I., El-Rifai, W. M., Garcia-Buitrago, M. T., Piazuelo, M. B., Wilson, K. T., Peek, R. M., & Zaika, A. I. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130015 · Cited by 59
LRH-1 drives colon cancer cell growth by repressing the expression of theCDKN1Agene in a p53-dependent manner
Kramer, H. B., Lai, C., Patel, H., Periyasamy, M., Lin, M., Feller, S. M., Fuller-Pace, F. V., Meek, D. W., Ali, S., & Buluwela, L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv948 · Cited by 59
Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition
Badodi, S., Baruffaldi, F., Ganassi, M., Battini, R., & Molinari, S. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1026519 · Cited by 59
p53‐Dependent subcellular proteome localization following DNA damage
Boisvert, F., & Lamond, A. I. (2010) · PROTEOMICS · doi:10.1002/pmic.201000213 · Cited by 59
Glyoxalase II, a Detoxifying Enzyme of Glycolysis Byproduct Methylglyoxal and a Target of p63 and p73, Is a Pro-survival Factor of the p53 Family
Xu, Y., & Chen, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604758200 · Cited by 60
Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2
Huang, W.-Y., Yang, P., Chang, Y.-F., Márquez, V. E., & Chen, C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.014 · Cited by 62
Depletion of the Poly(C)-binding Proteins αCP1 and αCP2 from K562 Cells Leads to p53-independent Induction of Cyclin-dependent Kinase Inhibitor (CDKN1A) and G1 Arrest
Waggoner, S. A., Johannes, G. J., & Liebhaber, S. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806986200 · Cited by 59
hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas
Xu, S., Feng, Z., Zhang, M., Wu, Y., Sang, Y., Xu, H., Lv, X., Hu, K., Cao, J., Zhang, R., et al. (2011) · Oncogene · doi:10.1038/onc.2010.596 · Cited by 59
Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress
Hoeferlin, L. A., Oleinik, N. V., Krupenko, N. I., & Krupenko, S. A. (2011) · Genes & Cancer · doi:10.1177/1947601911432495 · Cited by 59
Auranofin Protects Intestine against Radiation Injury by Modulating p53/p21 Pathway and Radiosensitizes Human Colon Tumor
Nag, D., Bhanja, P., Riha, R., Sánchez-Guerrero, G., Kimler, B. F., Tsue, T. T., Lominska, C. E., & Saha, S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2751 · Cited by 59
Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: Implications for evaluation of clinical radiosensitivity
Mirzayans, R., Severin, D. M., & Murray, D. L. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.08.064 · Cited by 60
Differential regulation of transcription and induction of programmed cell death by human p53‐family members p63 and p73
Dietz, S., Rother, K., Bamberger, C., Schmale, H., Mössner, J., & Engeland, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03093-4 · Cited by 60
NS1- and Minute Virus of Mice-Induced Cell Cycle Arrest: Involvement of p53 and p21 cip1
Beeck, A. O. D., Sobczak‐Thépot, J., Sirma, H., Bourgain‐Guglielmetti, F., Bréchot, C., & Caillet-Fauquet, P. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.11071-11078.2001 · Cited by 59
Molecular mechanisms of G0/G1 cell‐cycle arrest and apoptosis induced by terfenadine in human cancer cells
Liu, J.-D., Wang, Y., Chen, C.-H., Yu, C.-F., Chen, L.-C., Lin, J.-K., Liang, Y., Lin, S.-Y., & Ho, Y. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10118 · Cited by 59
DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21WAF1/CIP1
Xu, S., Huang, H., Chen, Y.-N., Deng, Y.-T., Zhang, B., Xiong, X.-D., Yuan, Y., Zhu, Y., Huang, H., Xie, L., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1224043 · Cited by 59
Herbal diterpenoids induce growth arrest and apoptosis in colon cancer cells with increased expression of the nonsteroidal anti-inflammatory drug-activated gene
Ko, J. K.-S., Leung, W. C., Ho, W. K., & Chiu, P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.004 · Cited by 58
Maintenance of imaginal disc plasticity and regenerative potential in Drosophila by p53
Wells, B. S., & Johnston, L. A. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.10.012 · Cited by 62
Elevated Cyclin G2 Expression Intersects with DNA Damage Checkpoint Signaling and Is Required for a Potent G2/M Checkpoint Arrest Response to Doxorubicin
Zimmermann, M., Don, A. S. A., Donaldson, M. S., Dallapiazza, R. F., Cowan, C. E., & Horne, M. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.376855 · Cited by 63
Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK
Bu, H., LIU, D.-L., Wei, W., Chen, L., Huang, H., Li, Y., & Cui, J. (2013) · Oncology Reports · doi:10.3892/or.2013.2888 · Cited by 59
Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy Resistance
Bolesta, E., Pfannenstiel, L. W., Demelash, A., Lesniewski, M. L., Tobin, M., Schlanger, S. E., Nallar, S. C., Papadimitriou, J. C., Kalvakolanu, D. V., & Gastman, B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06214-11 · Cited by 60
Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation.
Scott, S. L., Earle, J. D., & Gumerlock, P. H. (2003) · PubMed · Cited by 58
Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
Kitagaki, J., Agama, K., Pommier, Y. G., Yang, Y., & Weissman, A. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0063 · Cited by 58
Identification of TRIML2, a Novel p53 Target, that Enhances p53 SUMOylation and Regulates the Transactivation of Proapoptotic Genes
Kung, C.-P., Khaku, S., Jennis, M., Zhou, Y., & Murphy, M. E. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0385 · Cited by 58
Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex
Fischer, M., Quaas, M., Nickel, A., & Engeland, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6356 · Cited by 60
Induction and Validation of Cellular Senescence in Primary Human Cells
Hernandez‐Segura, A., Brandenburg, S. M., & Demaria, M. (2018) · Journal of Visualized Experiments · doi:10.3791/57782 · Cited by 64
Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma
Nieto-Rementería, N., Pérez‐Yarza, G., Boyano, M. D., Apraiz, A., Izu, R., Díaz-Pérez, J. L., & Asumendi, A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08931.x · Cited by 58
Transient Nutlin-3a Treatment Promotes Endoreduplication and the Generation of Therapy-Resistant Tetraploid Cells
Shen, H., Moran, D. M., & Maki, C. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1901 · Cited by 64
APE1/Ref-1 regulates PTEN expression mediated by Egr-1
Fantini, D., Fantini, D., Vascotto, C., Deganuto, M., Bivi, N., Gustincich, S., Marcon, G., Quadrifoglio, F., Damante, G., Bhakat, K. K., et al. (2008) · Free Radical Research · doi:10.1080/10715760701765616 · Cited by 58
FHL2 Regulates Cell Cycle-Dependent and Doxorubicin-Induced p21Cip1/Waf1 Expression in Breast Cancer Cells
Martin, B. T., Kleiber, K., Wixler, V., Raab, M., Zimmer, B., Kaufmann, M., & Strebhardt, K. (2007) · Cell Cycle · doi:10.4161/cc.6.14.4448 · Cited by 58
Transcriptional Activation of the Insulin-Like Growth Factor I Receptor Gene by the Kruppel-Like Factor 6 (KLF6) Tumor Suppressor Protein: Potential Interactions between KLF6 and p53
Rubinstein, M., Idelman, G., Plymate, S. R., Narla, G., Friedman, S. L., & Werner, H. (2004) · Endocrinology · doi:10.1210/en.2004-0173 · Cited by 58
Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites
Rossi, M., Demidov, O. N., Anderson, C. W., Appella, E., & Mazur, S. J. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn888 · Cited by 57
GTSE1 Is a Microtubule Plus-End Tracking Protein That Regulates EB1-Dependent Cell Migration
Scolz, M., Widlund, P. O., Piazza, S., Bublik, D. R., Reber, S., Peche, L. Y., Ciani, Y., Hubner, N. C., Isokane, M., Monte, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051259 · Cited by 57
N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence
Wang, Z., Liu, Y., Takahashi, M., Hook, K. V., Kampa-Schittenhelm, K. M., Sheppard, B. C., Sears, R. C., Stork, P. A., & Lopez, C. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201514110 · Cited by 57
Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231
Choi, Y. K., Seo, H. S., Choi, H. S., Choi, H. S., Kim, S. R., Shin, Y. C., & Ko, S. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1164-z · Cited by 57
VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis
Foersch, S., Sperka, T., Lindner, C., Taut, A., Rudolph, K. L., Breier, G., Boxberger, F., Rau, T. T., Hartmann, A., Stürzl, M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.016 · Cited by 57
Neem oil limonoids induces p53-independent apoptosis and autophagy
Srivastava, P., Yadav, N., Lella, R. K., Schneider, A., Jones, A., Marlowe, T. A., Lovett, G. H., O’Loughlin, K. L., Minderman, H., Gogada, R., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs269 · Cited by 57
Structural Basis of Restoring Sequence-Specific DNA Binding and Transactivation to Mutant p53 by Suppressor Mutations
Suad, O., Rozenberg, H., Brosh, R., Diskin‐Posner, Y., Kessler, N., Shimon, L. J. W., Frolow, F., Liran, A., Rotter, V., & Shakked, Z. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.063 · Cited by 58
Negative Regulation of p53 by the Long Isoform of ErbB3 Binding Protein Ebp1 in Brain Tumors
Kim, C. K., Nguyen, T. L. X., Joo, K. M., Nam, D., Park, J., Lee, K., Cho, S. W., & Ahn, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1882 · Cited by 57
Mdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells
Feeley, K. P., Adams, C. M., Mitra, R., & Eischen, C. M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0809 · Cited by 57
Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension
Wang, Z., Yang, K., Zheng, Q., Zhang, C., Tang, H., Babicheva, A., Jiang, Q., Li, M., Chen, Y., Carr, S. G., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00538.2017 · Cited by 58
Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway
Li, Y., Mao, Y., Brandt-Rauf, P. W., Williams, A. C., & Fine, R. L. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0206 · Cited by 57
Essential oil Composition and Antioxidant Activity of Pterocarya fraxinifolia
Ebrahimzadeh, M. A., Nabavi, S. F., & Nabavi, S. M. (2009) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2009.957.963 · Cited by 57
Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation
Hurley, P. J., Wilsker, D. F., & Bunz, F. (2006) · Oncogene · doi:10.1038/sj.onc.1210049 · Cited by 57
Self-citation
The Human Pre-B Cell Line Nalm-6 Is Highly Proficient in Gene Targeting by Homologous Recombination
Adachi, N., So, S., Iiizumi, S., Nomura, Y., Murai, K., Yamakawa, C., Miyagawa, K., & Koyama, H. (2006) · DNA and Cell Biology · doi:10.1089/dna.2006.25.19 · Cited by 57
Novel boronated derivatives of 5,10,15,20-tetraphenylporphyrin: Synthesis and toxicity for drug-resistant tumor cells
Ol’shevskaya, V. A., Зайцев, А. В., Luzgina, V. N., Kondratieva, T. T., Ivanov, O. G., Kononova, E. G., Petrovskii, P. V., Миронов, А. Ф., Kalinin, V. N., Hofmann, J., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.07.067 · Cited by 57
p21CIP1 Is Dispensable for the G2 Arrest Caused by Genistein in Human Melanoma Cells
Casagrande, F., & Darbon, J.-M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4914 · Cited by 57
p21 promotes error-free replication-coupled DNA double-strand break repair
Mauro, M., Rego, M. A., Boisvert, R. A., Esashi, F., Cavallo, F., Jasin, M., & Howlett, N. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks612 · Cited by 56
Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling
Hubáčková, S., Nováková, Z., Krejčíková, K., Košař, M., Dobrovolná, J., Dušková, P., Hanzlíková, H., Vančurová, M., Baráth, P., Bártek, J., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12521 · Cited by 60
Involvement of p53 in phthalate effects on mouse and rat osteoblasts
Sabbieti, M. G., Agas, D., Santoni, G., Materazzi, S., Menghi, G., & Marchetti, L. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22127 · Cited by 56

Authors: Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B.
Affiliations: Howard Hughes Medical Institute (US)
F. Bunz, S. Zhou, B. Vogelstein, The Howard Hughes Medical Institute and The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231, USA. C. Lengauer and K. W. Kinzler, The Johns Hopkins Oncology Center, Baltimore, MD 21231, USA. A. Dutriaux, J. P. Brown, J. Sedivy, Department of Molecular Biology, Cell Biology, and Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA. T. Waldman, Program in Human Genetics and the Johns Hopkins Oncology...
Corresponding author: Vogelstein, B.
ORCID: Bunz, F.
Dutriaux, A.
Waldman, T.
Zhou, S.
Brown, J. P.
Sedivy, J. M.
Kinzler, K. W.
Vogelstein, B.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1998-11-20
Volume: 282
Issue: 5393
Pages: 1497-1501
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.282.5393.1497
OpenAlex: W2080125477
Cited by: 2,803
References: 50
Citations by year: 2026: 28 · 2025: 39 · 2024: 42 · 2023: 60 · 2022: 69 · 2021: 86 · 2020: 77 · 2019: 76 · 2018: 98 · 2017: 101 · 2016: 103 · 2015: 97 · 2014: 113 · 2013: 155 · 2012: 120
FWCI: 41.60
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 57345, CA43460, P50CA062924, CA 62924)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords: p53, p21, G2 checkpoint, DNA damage, cell cycle arrest, cyclin-dependent kinase inhibitors, transcriptional activation, gamma radiation, cytokinesis, mitosis, gene disruption
MeSH terms: Cell Line, DNA, DNA Damage, Gamma Rays, Gene Expression Regulation, Humans, Mitosis, Mutation, Tumor Cells, Cultured, Nocodazole, Genes, p53, Tumor Suppressor Protein p53, G2 Phase, CDC2 Protein Kinase, Cyclins, Apoptosis, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21, Cyclin B1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks